Dr Reddy's receives FDA 483 at Indian API plant

By Dan Stanton contact

- Last updated on GMT

The US FDA has issued a Form 483 with four observations to an API facility in Hyderabad, India run by Dr Reddy’s Laboratories.

In a filing with the Bombay Stock Exchange, Indian drugmaker Dr Reddy’s said the US Food and Drug Administration (FDA) completed an audit at an active pharmaceutical ingredient (API) plant in Hyderabad in the Indian state of Telangana Friday.

“We have been issued a Form 483 with four observations which will be addressed comprehensively within stipulated time.”

A company spokesperson could comment neither on the APIs made at the plant nor the observations, beyond what was said to the exchange.

But "we believe that there will not be an delays in the current production,"​ we were told.

According to the firm, the Hyderabad site serves as the corporate centre for Dr. Reddy’s custom pharma services (CPS) business, and includes six commercial API production units, six pilot plants and two kilo labs, and over two million litres of reactor capacity.

The 483 is the latest regulatory action to hit Dr Reddy’s network. In 2017​, a Form 483 with three observations was sent to an API plant in Miryalaguda, Talangana.

Three other Dr Reddy run plants also received 483s last year. They were a finished dosage form site in Duvvada​​, an API plant in Srikakulam​​ and a generic drug facility in Bachupally​​.

Related news

Show more

Related products

Accelerate your supply chain as pressures intensify

Accelerate your supply chain as pressures intensify

William Reed | 17-Sep-2018 | Technical / White Paper

Food, Drink and Non-Food manufacturers are under pressure. Range reviews, massive retail mergers, the backlash against plastic packaging and the ongoing...

Strategies to Select and Deliver the Right Candidate

Strategies to Select and Deliver the Right Candidate

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

Does your candidate have what it takes to succeed? Do you have the information needed to make the right decisions about your candidate’s path to the clinic?...


Optimizing vessel geometry for mag drive agitators

Steridose, Inc | 14-Sep-2017 | Technical / White Paper

The performance of a bottom mount magnetically driven agitator (mag drive mixer) is heavily dependent on its relationship with the vessel’s geometry, baffles,...

Related suppliers